BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/28/2020 4:54:43 AM | Browse: 393 | Download: 565
Publication Name World Journal of Clinical Cases
Manuscript ID 56438
Country/Territory China
Received
2020-04-30 08:17
Peer-Review Started
2020-04-30 08:18
To Make the First Decision
Return for Revision
2020-05-21 06:07
Revised
2020-06-01 16:43
Second Decision
2020-09-07 10:08
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-09-08 00:52
Articles in Press
2020-09-08 00:52
Publication Fee Transferred
Edit the Manuscript by Language Editor
2020-09-12 20:46
Typeset the Manuscript
2020-09-22 14:40
Publish the Manuscript Online
2020-09-28 01:45
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, Research & Experimental
Manuscript Type Minireviews
Article Title Liver injury in COVID-19: A minireview
Manuscript Source Invited Manuscript
All Author List Jian-Nan Zhao, Ying Fan and Shuo-Dong Wu
Funding Agency and Grant Number
Corresponding Author Ying Fan, MD, PhD, Doctor, Professor, Department of General Surgery, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang 110004, Liaoning, China. coolingpine78@163.com
Key Words Liver injury; COVID-19; Novel coronavirus; SARS-CoV-2; Hepatoprotective drugs; Pandemic
Core Tip Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2. Liver injury was observed in COVID-19 patients especially in severe and critical types. Liver injury presented differentially based on disease severity, geographical areas, and patient age. It may be related to systemic inflammatory response, immune damage, ischemia-reperfusion injury, viral direct damage, drug induce, mechanical ventilation, and underlying diseases. Special treatment is not necessary in most mild liver injury cases and only one or two types of hepatoprotective drugs should be used to treat significant liver injury. Monitoring liver function is important parameter during the treatment of COVID-19 as it affects survival and recovery of patients, and its significance should be emphasized for doctors treating the disease. The risk of COVID-19 infection in liver transplantation recipients was not increased.
Publish Date 2020-09-28 01:45
Citation Zhao JN, Fan Y, Wu SD. Liver injury in COVID-19: A minireview. World J Clin Cases 2020; 8(19): 4303-4310
URL https://www.wjgnet.com/2307-8960/full/v8/i19/4303.htm
DOI https://dx.doi.org/10.12998/wjcc.v8.i19.4303
Full Article (PDF) WJCC-8-4303.pdf
Full Article (Word) WJCC-8-4303.docx
Manuscript File 56438-Review-Filipodia.docx
Answering Reviewers 56438-Answering reviewers.pdf
Audio Core Tip 56438-Audio core tip.wma
Conflict-of-Interest Disclosure Form 56438-Conflict-of-interest statement.pdf
Copyright License Agreement 56438-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 56438-Language certificate.pdf
Peer-review Report 56438-Peer-review(s).pdf
Scientific Misconduct Check 56438-Scientific misconduct check.pdf
Scientific Editor Work List 56438-Scientific editor work list.pdf